State Ledger
Company profile

Cue Biopharma, Inc. CIK 1645460

Ticker
CUE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA 02135
Fiscal year end
2025 (FY)
Market Data
Close
$24.96
Change
-$2.75
Change %
-9.92%
Volume
1,838

CUE · trading date Oct 12, 2026 · previous close $27.71 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$27.47M
Net income
-$26.60M
Total assets
$42.21M
Total liabilities
$15.78M
Stockholders' equity
$26.43M
Cash & equivalents
$27.14M
Operating income
-$26.55M
Operating cash flow
-$21.69M
Capital expenditures
$177.0K

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-96.7%
Net margin
-96.9%
Free cash flow
-$21.86M
Free cash flow margin
-79.6%
Liabilities / assets
37.4%
Equity / assets
62.6%
CapEx / revenue
0.6%
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $27.47M -$26.60M $42.21M $15.78M $26.43M
2024 $9.29M -$40.67M $32.19M $14.69M $17.50M
2023 $5.49M -$50.73M $61.53M $24.45M $37.09M
2022 $1.25M -$53.01M $91.28M $25.60M $65.68M
2021 $14.94M -$44.16M $83.40M $17.91M $65.49M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4/A
2026-08-28
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02135
40 GUEST STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies